NBG 050
Alternative Names: NBG-050Latest Information Update: 31 Jul 2023
At a glance
- Originator NB Health Laboratory
- Class Monoclonal antibodies; Vascular disorder therapies
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Stroke
Highest Development Phases
- Research Stroke
Most Recent Events
- 20 Jul 2023 NBG 050 is available for licensing as of 20 Jul 2023. https://nbhl.co.jp/partnering/
- 20 Jul 2023 Early research in Stroke in Japan (Parenteral)